Company / Book Value per Share
Trevi Therapeutics, Inc. Book Value per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.977
FY2024
5-year range
$0.748 / $1.665
FY2020-FY2024
Trend
+17.2%
vs FY2023
Sector context
#166 of 209
Health Care
What the data says
Trevi Therapeutics, Inc.'s book value per share of $0.977 is lower than 79% of companies in the Health Care sector (FY2024). Book Value per Share has fluctuated over the past 7 years, ranging from -$250.209 in FY2018 to $4.648 in FY2019.
Based on SEC 10-K filings.
$0.977 in FY2024 with a 5-year CAGR of -26.8%.
Declined from $1.665 to $0.977 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +9.3%
- 5-Year CAGR
- -26.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 209This company $0.977 Sector average $189.406
▼
-99.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -26.8%, indicating a declining trend.
- In FY2024, book value per share increased 17.2% year-over-year.
- Ranks #166 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.977 | +17.2% |
| FY2023 | $0.834 | -49.9% |
| FY2022 | $1.665 | +122.7% |
| FY2021 | $0.748 | -50.5% |
| FY2020 | $1.511 | -67.5% |
| FY2019 | $4.648 | +101.9% |
| FY2018 | -$250.209 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026